These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient. Abbas O; Shamseddin A; Temraz S; Haydar A BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23436889 [TBL] [Abstract][Full Text] [Related]
11. Posterior reversible encephalopathy syndrome with bevacizumab. Lau PC; Paunipagar B Hong Kong Med J; 2011 Feb; 17(1):80-1. PubMed ID: 21282833 [No Abstract] [Full Text] [Related]
14. Reversible skeletal changes after treatment with bevacizumab in a child with cutaneovisceral angiomatosis with thrombocytopenia syndrome. Smith AR; Hennessy JM; Kurth MA; Nelson SC Pediatr Blood Cancer; 2008 Sep; 51(3):418-20. PubMed ID: 18493993 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension. Dincer M; Altundag K Ann Pharmacother; 2006 Dec; 40(12):2278-9. PubMed ID: 17105834 [No Abstract] [Full Text] [Related]